does semaglutide contain sulfa Allergy to Medications: Drugs to Avoid FDA Warns on Certain Forms

A 2024 study from the International Foundation of Employee Benefit Plans showed that employer coverage of GLP-1s is still limited, with 34% of corporate plans currently providing coverage for non-diabetic patients who want to lose weight (up 8 percentage points from 2023)

LAURIE SUND: First of all, just letting you know I'm really passionate about this, because obesity is the second leading cause of preventable illness and death, and 42% of our population has obesity

Diabetes 61:12431249 Pfeffer MA, Claggett B, Diaz R et al (2015) Lixisenatide in patients with type 2 diabetes and acute coronary syndrome

For research protocols using the 10mg or 12mg maintenance dose, the injection volume should be accounted for in the reconstitution plan